Walleye Trading LLC Vanda Pharmaceuticals Inc. Transaction History

Walleye Trading LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$9.31 - $11.84 $49,640 - $63,130	-5,332 Reduced 51.25%	5,072 $55,000
Q1 2022 May 16, 2022	SELL	$10.84 - $16.55 $39,403 - $60,159	-3,635 Reduced 25.89%	10,404 $118,000
Q3 2021 Nov 15, 2021	SELL	$15.35 - $21.27 $116,322 - $161,184	-7,578 Reduced 35.06%	14,039 $241,000
Q2 2021 Aug 16, 2021	BUY	$15.71 - $21.51 $339,603 - $464,981	21,617 New	21,617 $465,000
Q1 2020 May 15, 2020	SELL	$7.5 - $16.8 $8,160 - $18,278	-1,088 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$12.38 - $17.47 $13,469 - $19,007	1,088 New	1,088 $18,000
Q1 2019 May 15, 2019	SELL	$17.59 - $31.05 $147,404 - $260,199	-8,380 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$18.97 - $31.47 $158,968 - $263,718	8,380 New	8,380 $219,000

161

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $282M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.